Jana Kordulakova
Overview
Explore the profile of Jana Kordulakova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mistretta M, Cimino M, Campagne P, Volant S, Kornobis E, Hebert O, et al.
Nat Commun
. 2024 May;
15(1):4175.
PMID: 38755132
Drug-recalcitrant infections are a leading global-health concern. Bacterial cells benefit from phenotypic variation, which can suggest effective antimicrobial strategies. However, probing phenotypic variation entails spatiotemporal analysis of individual cells that...
2.
Savkova K, Danchenko M, Fabianova V, Bellova J, Bencurova M, Huszar S, et al.
J Biol Chem
. 2024 Feb;
300(3):105768.
PMID: 38367664
Galactan polymer is a prominent component of the mycobacterial cell wall core. Its biogenesis starts at the cytoplasmic side of the plasma membrane by a build-up of the linker disaccharide...
3.
Karabanovich G, Fabianova V, Vocat A, Dusek J, Valaskova L, Stolarikova J, et al.
J Med Chem
. 2023 Dec;
67(1):81-109.
PMID: 38157261
3,5-Dinitrobenzylsulfanyl tetrazoles and 1,3,4-oxadiazoles, previously identified as having high activities against both replicating and nonreplicating mycobacteria and favorable cytotoxicity and genotoxicity profiles were investigated. First we demonstrated that these compounds...
4.
Novel pyrimidine-1,3,4-oxadiazole hybrids and their precursors as potential antimycobacterial agents
Pflegr V, Stolarikova J, Pal A, Kordulakova J, Kratky M
Future Med Chem
. 2023 Aug;
15(12):1049-1067.
PMID: 37555280
Molecular hybridization and isostery are proven approaches in medicinal chemistry, and as such we used them to design novel compounds that we investigated as potential antimycobacterials to combat drug-resistant strains....
5.
Bouz G, Slechta P, Jandourek O, Konecna K, Paterova P, Barta P, et al.
ACS Infect Dis
. 2023 Jul;
9(8):1674.
PMID: 37486740
No abstract available.
6.
Chebaiki M, Delfourne E, Tamhaev R, Danoun S, Rodriguez F, Hoffmann P, et al.
Eur J Med Chem
. 2023 Jul;
259:115646.
PMID: 37482022
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) affects 10 million people each year and the emergence of resistant TB augurs for a growing incidence. In the last 60 years, only...
7.
Nawrot D, Bouz G, Jandourek O, Konecna K, Paterova P, Barta P, et al.
Eur J Med Chem
. 2023 Jul;
258:115617.
PMID: 37423128
Tuberculosis is the number one killer of infectious diseases caused by a single microbe, namely Mycobacterium tuberculosis (Mtb). The success rate of curing this infection is decreasing due to emerging...
8.
Faion L, Djaout K, Pintiala C, Piveteau C, Leroux F, Biela A, et al.
Pharmaceuticals (Basel)
. 2023 Mar;
16(3).
PMID: 36986435
, the pathogen that causes tuberculosis, is responsible for the death of 1.5 million people each year and the number of bacteria resistant to the standard regimen is constantly increasing....
9.
Bouz G, Slechta P, Jandourek O, Konecna K, Paterova P, Barta P, et al.
ACS Infect Dis
. 2022 Dec;
9(1):79-96.
PMID: 36577009
Apart from the SARS-CoV-2 virus, tuberculosis remains the leading cause of death from a single infectious agent according to the World Health Organization. As part of our long-term research, we...
10.
Salina E, Postiglione U, Chiarelli L, Recchia D, Zahorszka M, Lepioshkin A, et al.
mSphere
. 2022 Nov;
7(6):e0036922.
PMID: 36377880
Tuberculosis (TB) still poses a global menace as one of the deadliest infectious diseases. A quarter of the human population is indeed latently infected with Mycobacterium tuberculosis. People with latent...